Results 21 to 30 of about 6,488,586 (257)

Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease [PDF]

open access: yes, 2014
Claire Brockwell,1 Sundari Ampikaipakan,1,2 Darren W Sexton,1 David Price,3,4 Daryl Freeman,5 Mike Thomas,6 Muzammil Ali,4 Andrew M Wilson1,21Norwich Medical School, University of East Anglia, Norwich, UK; 2Norfolk and Norwich University Hospital ...
Freeman, D   +24 more
core   +1 more source

A comparison of HTLV-1 Infection Frequency in Patients with or without Tuberculosis [PDF]

open access: yesJournal of Cardio-Thoracic Medicine, 2014
Introduction: To recognize the predisposing factors in tuberculosis as an endemic infection in Northeast province of Iran, this study was aimed to evaluate whether HumanT-lymphocyte type 1 (HTLV-I) as an immunosuppressive factor increases the risk of ...
Leila Ghofraniha   +6 more
doaj   +2 more sources

Auditory function assessment in patients with chronic obstructive pulmonary disease

open access: yesSAGE Open Medicine, 2023
Background: Chronic obstructive pulmonary disease is a multisystem disease with multiple comorbidities. Hearing is dependent on the cochlear functions that may be affected by oxygenation. Affection of hearing is problematic and represents a major concern
Hoda A Eid   +13 more
doaj   +1 more source

Prediction of disease progression, treatment response and dropout in chronic obstructive pulmonary disease (COPD). [PDF]

open access: yes, 2014
Drug development in chronic obstructive pulmonary disease (COPD) has been characterised by unacceptably high failure rates. In addition to the poor sensitivity in forced expiratory volume in one second (FEV1), numerous causes are known to contribute to ...
Musuamba, F.T.   +20 more
core   +1 more source

Models of chronic obstructive pulmonary disease [PDF]

open access: yes, 2004
Chronic obstructive pulmonary disease (COPD) is a major global health problem and is predicted to become the third most common cause of death by 2020. Apart from the important preventive steps of smoking cessation, there are no other specific treatments ...
David A Groneberg   +5 more
core   +1 more source

Clinical characteristics of Japanese patients with chronic obstructive pulmonary disease (COPD) with comorbid interstitial lung abnormalities: A cross-sectional study.

open access: yesPLoS ONE, 2020
Smoking-related interstitial lung abnormalities are different from specific forms of fibrosing lung disease which might be associated with poor prognoses.
Manabu Ono   +6 more
doaj   +1 more source

Prevalence of depression and anxiety in patients with chronic obstructive pulmonary disease and their association with psychosocial outcomes: A cross-sectional study from Pakistan

open access: yesSAGE Open Medicine, 2021
Objectives: Chronic obstructive pulmonary disease contributes to substantial health and economic burden worldwide. Co-morbid depression and anxiety are highly prevalent in patients with chronic obstructive pulmonary disease.
Muhammad Omair Husain   +10 more
doaj   +1 more source

Bronchiectasis in patients with chronic obstructive pulmonary disease

open access: yesJournal of Pathology of Nepal, 2018
Background: Chronic obstructive pulmonary disease is most common disease entity and third leading cause of mortality worldwide. The presence of bronchiectasis in severe chronic obstructive pulmonary disease patients had led to frequent exacerbation ...
Milesh Jung Sijapati   +4 more
doaj   +1 more source

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease. [PDF]

open access: yes, 2011
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Developments in the understanding of COPD have led to standard guidelines for diagnosis, treatment, and spirometry assessments, which have in turn ...
James Donohue   +5 more
core   +1 more source

Comparative Study on the Quality of Life of Chronic Obstructive Pulmonary Disease Patients [PDF]

open access: yes
Objective: The main goal of this study is to compare the Quality of Life (QoL) of Chronic Obstructive Pulmonary Disease (COPD) patients between three different regions: the United Arab Emirates (UAE), the United Kingdom (UK) and Morocco. Another aim of
Bihi, Imane Ben
core   +6 more sources

Home - About - Disclaimer - Privacy